Debra A. Minjarez

No ORCID on file · 4 papers in corpus · active 2000-2009

Study types

  • article 2
  • other 1
  • review 1

Condition tags

  • endometriosis 3
  • infertility 1
article 2009
Does endometrial integrin expression in endometriosis patients predict enhanced in vitro fertilization cycle outcomes after prolonged GnRH agonist therapy?
Fertility and sterility ·doi:10.1016/j.fertnstert.2008.12.023

ObjectiveTo determine whether endometrial expression of the integrin alpha(v)beta(3) vitronectin can predict which endometriosis patient subgroup will benefit from pre-IVF cycle prolonged GnRH agonist (GnRHa) therapy.DesignProspective rando…

other 2007
The incidence of aberrant endometrial alphavbeta(3) vitronectin expression in a high risk infertility population: could prolonged GnRH agonist therapy play a role?
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-007-9164-3

PURPOSE: Evaluate the incidence of aberrant endometrial integrin (alphavbeta(3) vitronectin) expression in patients at high risk for implantation defects. MATERIALS AND METHODS: Retrospective case-control trial of 74 consecutive infertile …

article 2001
Regulation of Uterine 5α-Reductase Type 1 in Mice1
·doi:10.1095/biolreprod65.5.1378

A null mutation in the murine gene encoding steroid 5 alpha-reductase type 1 (5 alpha R1) leads to failure of normal parturition at term. This observation, together with the finding that mRNA levels of uterine 5 alpha R1 increase significan…

review 2000
UPDATE ON THE MEDICAL TREATMENT OF ENDOMETRIOSIS
Obstetrics and gynecology clinics of North America ·doi:10.1016/s0889-8545(05)70161-3

The treatment of women with endometriosis can be a challenge. Therapeutic strategies must be tailored to the individual symptoms, age, and desire for fertility. Medical therapy continues to be based on endocrine treatment, such as oral cont…